Anderson Mark Lewis
Known title: DirectorCIK: 0002067289
Anderson Mark Lewis's purchase track record
How the stock did after each of Anderson Mark Lewis's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since April 24, 2025
Stock higher 6 months later
67%
3 months: 33%
Median 6-month return
+6.1%
3 months: 0.0%
Beat the S&P 500
33%
median -6.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/18/2026 | SINT | $9K | -26.3% | -48.3% | +12.0% |
| 6/18/2025 | SINT | $33K | +19.1% | +6.1% | +12.4% |
| 4/24/2025 | SINT | $12K | 0.0% | +27.2% | +22.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SINT | ▲ Buy | Open Market | 3,000 | $9K | 2/18/2026 | View on chart |
| SINT | ▲ Buy | Open Market | 10,000 | $33K | 6/18/2025 | View on chart |
| SINT | ▲ Buy | Open Market | 5,000 | $12K | 4/24/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SINTX Q3 Revenue Tops Guidance; Analyst Raises Target
SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.
SINTX Q3 Revenue Tops Guidance; Analyst Raises Target. SiNtx Technologies reported preliminary Q3 revenue of $2.2 million, significantly exceeding its previous guidance range of $0.9 million to $1.1 million. Following this update, Ascendiant Capital raised its price target to $12.50. This strong revenue performance stands out against the stock's 52-week range of $1.40 to $4.66.